08225 中國醫療集團
按盘价 
0.160 0.000 (0.000%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | -13.181% | -38.939% | -8.487% | 20.510% | 44.739% |
| 股东资金回报率 (%) | -18.713% | -51.082% | -10.625% | 26.491% | 69.056% |
| 资本运用回报率 (%) | -20.826% | -68.914% | -11.154% | 23.349% | 51.106% |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 38.055% | 38.329% | 43.873% | 76.383% | -- |
| 未计利息、税项、折旧及摊销前利润率 (%) | -52.657% | -271.146% | -121.161% | 50.606% | 85.747% |
| 税前边际利润率 (%) | -54.710% | -271.697% | -120.901% | 50.862% | 85.232% |
| 纯利率 (%) | -54.884% | -270.777% | -120.901% | 43.450% | 73.017% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 2.965 X | 3.190 X | 4.824 X | 4.974 X | 3.837 X |
| 速动比率 (X) | 2.965 X | 3.190 X | 4.824 X | 4.974 X | 3.837 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 30.946% | 29.465% | 20.569% | 19.942% | 25.779% |
| 总债项 / 总资产比率 (%) | 0% | 0% | 0% | 0% | 0.938% |
| 净债项 / 总资产比率 (%) | -14.059% | -3.469% | -2.273% | -5.848% | -9.189% |
| 总债项 / 股东资金比率 (%) | 0% | 0% | 0% | 0% | 1.264% |
| 长期债项 / 股东资金比率 (%) | 0% | 0% | 0% | 0% | 0% |
| 净债项 / 股东资金比率 (%) | -20.175% | -4.881% | -2.853% | -7.305% | -12.381% |
| 净现金 / (债项) ($) | 1.42千万 | 4.14百万 | 4.06百万 | 1.14千万 | 1.47千万 |
| 每股净现金 / (债项) ($) | 0.014 | 0.004 | 0.004 | 0.011 | 0.015 |
| 总债项 / 资本运用比率 (%) | 0% | 0% | 0% | 0% | 1.264% |
| 利息盈利率 (X) | N/A | N/A | N/A | 2835.733 X | 435.331 X |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 应收贸易帐周转率日数 (日) | 848.431日 | 1484.047日 | 3308.938日 | 468.402日 | 317.733日 |
| 应付贸易帐周转率日数 (日) | 41.613日 | 96.476日 | 179.558日 | 34.452日 | 34.124日 |
| 备注： | 实时报价更新时间为16/05/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -14,519,000 |
| 增长率 | -74.973% |
| 每股盈利/(亏损) | RMB -0.015 |
| 每股账面资产净值 (¥) | RMB 0.071 |